Single-arm studies of interferon-α (IFN-α) plus low-dose cytarbine.
| . | . | . | % Cytogenetic Response . | |
|---|---|---|---|---|
| Study (reference) . | No. Treated . | % CHR . | Complete . | Major . |
| MDACC(89) | ||||
| daily cytarabine | 134 | 92 | 31 | 50 |
| intermittent cytarabine | 54 | 84 | 20 | 38 |
| Arthur(91) | 30 | 93 | 30 | 53 |
| Thaler(92) | 84 | 54 | 18 | 25 |
| Silver(93) | 88 | 72 | 15 | 51 |
| Abbreviations: CHR, complete hematologic response; MDACC, M.D. Anderson Cancer Center | ||||
| . | . | . | % Cytogenetic Response . | |
|---|---|---|---|---|
| Study (reference) . | No. Treated . | % CHR . | Complete . | Major . |
| MDACC(89) | ||||
| daily cytarabine | 134 | 92 | 31 | 50 |
| intermittent cytarabine | 54 | 84 | 20 | 38 |
| Arthur(91) | 30 | 93 | 30 | 53 |
| Thaler(92) | 84 | 54 | 18 | 25 |
| Silver(93) | 88 | 72 | 15 | 51 |
| Abbreviations: CHR, complete hematologic response; MDACC, M.D. Anderson Cancer Center | ||||